Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1996
03/13/1996EP0700899A1 Substituted benzoylguanidines, a process for their preparation, their use as drug or diagnostic agents as well as medicaments containing them
03/13/1996EP0700898A1 L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
03/13/1996EP0700897A1 L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
03/13/1996EP0700896A1 Photochemically cleavable metal chelating agents and compositions containing them
03/13/1996EP0700681A1 Nutritional transfusion for peripheral vein administration
03/13/1996EP0700680A1 Gepirone dosage form
03/13/1996EP0700679A1 Injectable liposomal compositions
03/13/1996EP0700523A1 Embryotoxic factors
03/13/1996EP0700400A1 4-AMINO-17$g(b)-(CYCLOPROPYLOXY)ANDROST-4-EN-3-ONE, 4-AMINO-17$g(b)-(CYCLOPROPYLAMINO)ANDROST-4-EN-3-ONE AND RELATED COMPOUNDS AS C 17-20? LYASE AND 5$g(a)-REDUCTASE INHIBITORS
03/13/1996EP0700399A1 36-derivatives of rifamycins and their use as antimicrobial agents
03/13/1996EP0700398A1 Psoralen derivatives, their preparation and use as medicaments
03/13/1996EP0700397A1 New thiazolidindiones and drugs containing them
03/13/1996EP0700396A1 Piperidine derivatives, their preparation and use
03/13/1996EP0700389A1 Anti-arrhythmic n-substituted 3-benzazepines or isoquinolines
03/13/1996EP0700388A1 Substituted beta-aryl and beta-heteroaryl-alpha-cyanoacrylamide derivatives as tyrosine kinase inhibitors
03/13/1996EP0700387A1 Salts of substituted heteroaromatic nitrogen compounds, method for their preparation and pharmaceutical compounds containing same
03/13/1996EP0700386A1 Neurokinin receptor antagonists
03/13/1996EP0700385A1 Novel compounds
03/13/1996EP0700383A1 Novel 1-phenylalkanone 5-ht 4? receptor ligands
03/13/1996EP0700382A1 Novel n-arylaliphatic-n-alkyl-functionalised amides, method for their prepation and pharmaceutical compositions containing same
03/13/1996EP0700380A1 N-alkylthio polyamine derivatives as radioprotective agents
03/13/1996EP0700378A1 Compounds which release nitric oxide
03/13/1996EP0700376A1 Nitrobenzyl mustard quaternary salts and their use as hypoxia-selective cytotoxic agents
03/13/1996EP0700296A1 Use of lignan derivatives for the preparation of pharmaceutical compositions for the treatment of states of amyloidosis
03/13/1996EP0700295A1 Vitamin b 12? mediated oral delivery systems for gcsf and epo
03/13/1996EP0700294A1 Intramuscular and subcutaneous injection solution for animals
03/13/1996EP0700293A1 Dihydrotestosterone for use in androgenotherapy
03/13/1996EP0700292A1 Methods and compositions for treating gastric disorders using optically pure (+) pantoprazole
03/13/1996EP0700291A1 15-substituted 4-azasteroids
03/13/1996EP0700290A1 Rectal compositions
03/13/1996EP0700289A1 Antidepressant dosage form
03/13/1996EP0700288A1 Inhibition of hair growth
03/13/1996EP0700287A1 Arylating medicaments
03/13/1996EP0700286A1 Apoptosis inhibitors for treating neurodegenerative diseases
03/13/1996EP0700285A1 A drug delivery composition for alpha-adreno receptor blocking agents
03/13/1996EP0700284A1 Controlled release oxybutynin formulations
03/13/1996EP0700283A1 Liquid antacid compositions
03/13/1996EP0700282A1 Inhibition of hair growth
03/13/1996EP0700249A1 Anti-infective agents
03/13/1996EP0690841A4 Synthetic matrix metalloprotease inhibitors and uses thereof
03/13/1996EP0644760A4 Treatments for diseases characterized by neovascularization.
03/13/1996EP0618899B1 Aromatic esters of phenylenedialkanoates as inhibitors of human neutrophil elastase
03/13/1996EP0544880B1 Method of preparing diacetyl rhein
03/13/1996EP0540613B1 Products and processes for the treatment of the alimentary canal
03/13/1996EP0521974B1 Veterinary treatment
03/13/1996EP0502926B1 Anti-thrombotic peptides and pseudopeptides
03/13/1996EP0500905B1 Pharmaceutical compositions for use in treating aids
03/13/1996EP0500823B1 Antimalarial compositions
03/13/1996EP0495825B1 Use of antigestagens in the manufacture of medicaments
03/13/1996EP0489108B1 Use of spiperone derivatives for immunosuppression
03/13/1996EP0476113B1 Medicament for treating hyperlipidaemia and/or atherosclerosis
03/13/1996EP0455783B1 Use of nervonic acid and long chain fatty acids for the treatment of demyelinating disorders
03/13/1996EP0440772B1 Nucleic acid fragments and diagnostic reagents derived from the hhv6/sie genome and procedures for diagnosing hhv6 infections
03/13/1996EP0439513B1 Composition for inhibiting transmission of aids
03/13/1996EP0438497B1 Vasopermeability-enhancing conjugates
03/13/1996EP0436545B1 Therapeutic methods using catalytic antibodies
03/13/1996CN1118601A Inhibitors of herpes viral ribonucleotide reductase
03/13/1996CN1118599A Xanthine derivatives as adenosine A1 receptor antagonists
03/13/1996CN1118598A Pyrrolo-pyridine derivatives
03/13/1996CN1118595A Anthranilic acid derivative
03/13/1996CN1118575A Optical isomerization inhibitor
03/13/1996CN1118571A Bisacodyl dosage form
03/13/1996CN1118352A New steroids containing in position 20 an aminosubstitued chain, preparation procass and intermediates of this process, use as medicaments and pharmaceutical compositions containing them
03/13/1996CN1118349A Oxime derivatives of cephalosporanic structure and compounds for their preparation
03/13/1996CN1118348A Process for the preparation of 14,15-dihydro-14-hydroxy-(3,16)-eburnamenine-14-carboxylic acid
03/13/1996CN1118347A Benzotoudened 5-ringneterocycl, preparation and phamaceutical and diagnostic use of same
03/13/1996CN1118261A Medicine for hematosepsis of silver carp and variegated carp
03/13/1996CN1118255A Compounded composition for throat diseases
03/13/1996CN1118254A Pharmaceutical compositions having good dissolution properties
03/13/1996CN1118253A Metronizole effevescent tablet
03/13/1996CN1118252A Stabized solutions of platinum (II) antitumor agents
03/13/1996CN1031285C Process for preparing high-concentration mixtures of polyunsaturated fatty acids and their esters from oils of animal and/or vegetable origin
03/13/1996CN1031266C Process for preparation of heterocycle ether derivatives
03/13/1996CN1031262C Ring-substituted 2-animo-1,2,3,4-tetra hydronaphthalenes and 3-aminochromanes
03/13/1996CN1031238C Pesticidal 3-cyano-5-aloxy-1-arylpyrazoles
03/13/1996CA2157998A1 Pharmaceutical compounds
03/13/1996CA2157849A1 Injectable liposomal pharmaceutical preparations
03/12/1996US5498795 Acetylenes disubstituted with hydroxyaryl and aryl or heteroaryl groups having retinoid-like biological activity
03/12/1996US5498788 Inclusion complexes of clavulanic acid and of potassium salts thereof with hydrophobic β-cyclodextrin derivatives a process for the preparation thereof
03/12/1996US5498786 Enzyme inhibitors, cardiovascular disorders
03/12/1996US5498780 Platinum complex and malignant tumor treating drug containing the same
03/12/1996US5498776 Substituted pyrrolopyrimidines and pyridopyrimidines useful as angiotensin II antagonists
03/12/1996US5498775 Polyanionic benzylglycosides as inhibitors of smooth muscle cell proliferation
03/12/1996US5498745 Antiallergen intermediates, inhibitors of leukotrienes, lipoxygenase inhibitors
03/12/1996US5498729 Prodrug compositions
03/12/1996US5498728 Osteoporosis
03/12/1996US5498726 Preparation of physostigmine carbamate derivatives from physostigmine
03/12/1996US5498722 Hypotensives
03/12/1996US5498699 Complexes and chelates of azithromycin with bivalent and/or trivalent metals and their use as antiulcer
03/12/1996US5498636 Beta-adrenergic blocking agent such as propranolol and other compounds
03/12/1996US5498635 Tri(lower alkoxy) benzene derivatives
03/12/1996US5498633 Esters of acyl carnitines with long-chain aliphatic alcohols and pharmaceutical compositions containing same having antibacterial activity
03/12/1996US5498632 Bactericides
03/12/1996US5498631 Method for treatment of menopausal and premenstrual symptoms
03/12/1996US5498630 Fungicides for the control of take-all disease of plants
03/12/1996US5498628 Naphthamide derivatives
03/12/1996US5498626 Acylaminoindole derivatives as 5-ht1 agonists
03/12/1996US5498623 4(5) substituted imidazoles and their preparation and use
03/12/1996US5498622 An iron chelator, malaria
03/12/1996US5498620 Antitumor
1 ... 6935 6936 6937 6938 6939 6940 6941 6942 6943 6944 6945 6946 6947 6948 6949 6950 6951 6952 6953 6954 6955 ... 7860